Takashi Masuko Selected Research

Multiple Myeloma

1/2022

Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Masuko Research Topics

Disease

32	Neoplasms (Cancer) 09/2023 - 02/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2013
4	Colonic Neoplasms (Colon Cancer) 10/2021 - 09/2010
4	Hepatocellular Carcinoma (Hepatoma) 02/2021 - 05/2008
4	Carcinoma (Carcinomatosis) 01/2015 - 09/2010
3	Breast Neoplasms (Breast Cancer) 05/2023 - 06/2012
3	Inflammation (Inflammations) 01/2019 - 07/2013
3	Neoplasm Metastasis (Metastasis) 10/2018 - 09/2010
2	Squamous Cell Carcinoma of Head and Neck 11/2019 - 03/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2016 - 07/2013
2	Asthma (Bronchial Asthma) 09/2016 - 07/2013
2	Glioma (Gliomas) 01/2016 - 05/2009
2	Carcinogenesis 10/2013 - 03/2010
2	Neuroblastoma 01/2012 - 05/2009
2	Seizures (Absence Seizure) 11/2009 - 09/2007
2	Hyperalgesia 07/2006 - 09/2002
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022
1	Multiple Myeloma 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2021
1	Pulmonary Hypertension 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Ischemic Stroke 01/2018
1	Melanoma (Melanoma, Malignant) 07/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 09/2016
1	Bacterial Infections (Bacterial Infection) 09/2016
1	Brain Neoplasms (Brain Tumor) 01/2016
1	Metaplasia 10/2013
1	Respiratory Hypersensitivity 07/2013

Drug/Important Bio-Agent (IBA)

17	Monoclonal AntibodiesIBA 05/2023 - 02/2003
9	Proteins (Proteins, Gene)FDA Link 09/2023 - 07/2004
7	Amino Acid Transport Systems (Amino Acid Transporter)IBA 06/2021 - 05/2008
6	EpitopesIBA 01/2022 - 02/2003
5	ErbB Receptors (EGF Receptor)IBA 05/2023 - 01/2012
5	AntibodiesIBA 05/2022 - 01/2011
5	Amino Acids FDA Link 01/2020 - 07/2004
5	Cystine (L-Cystine)IBA 11/2019 - 06/2012
4	Green Fluorescent ProteinsIBA 02/2021 - 05/2008
4	Protein Isoforms (Isoforms)IBA 10/2013 - 01/2012
4	Peptide Hydrolases (Proteases)FDA Link 07/2006 - 09/2002
3	Complementary DNA (cDNA)IBA 01/2021 - 05/2008
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2019 - 10/2013
3	AntioxidantsIBA 11/2019 - 03/2013
3	Peptides (Polypeptides)IBA 01/2011 - 09/2003
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 11/2007
2	Hyaluronan ReceptorsIBA 01/2021 - 10/2018
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2016
2	Cysteine (L-Cysteine)FDA Link 01/2020 - 05/2008
2	Glutamine (L-Glutamine)FDA Link 01/2020 - 11/2019
2	Glutathione (Reduced Glutathione)IBA 11/2019 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 11/2019 - 01/2016
2	DisulfidesIBA 01/2019 - 05/2008
2	EnzymesIBA 01/2018 - 07/2013
2	PolyaminesIBA 01/2018 - 11/2009
2	LipopolysaccharidesIBA 09/2016 - 07/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016 - 07/2013
2	Large Neutral Amino Acid-Transporter 1IBA 01/2013 - 05/2008
2	Neuroprotective AgentsIBA 11/2009 - 09/2007
2	N-Methylaspartate (NMDA)IBA 11/2009 - 09/2007
2	Transferrin Receptors (Transferrin Receptor)IBA 05/2008 - 03/2008
2	seryl- leucyl- isoleucyl- glycyl- - arginyl- leucinamideIBA 07/2006 - 09/2003
1	Tyrosine Kinase InhibitorsIBA 09/2023
1	Therapeutic UsesIBA 05/2023
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 01/2023
1	patritumabIBA 01/2023
1	AntigensIBA 05/2022
1	Epithelial Cell Adhesion MoleculeIBA 05/2022
1	ProteomeIBA 01/2022
1	pertuzumabIBA 10/2021
1	Panitumumab (Vectibix)FDA Link 10/2021
1	Leucine (L-Leucine)FDA Link 06/2021
1	Neutral Amino AcidsIBA 06/2021
1	Calcibiotic Root Canal SealerIBA 02/2021
1	Cationic Amino Acid Transporter 1IBA 02/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Differentiation AntigensIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Alanine (L-Alanine)FDA Link 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Membrane Transport Proteins (Biological Pump)IBA 11/2019
1	AntiportersIBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2018
1	Polyamine OxidaseIBA 01/2018
1	1'-acetoxychavicol acetateIBA 07/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2017
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2017
1	U 0126 (UO 126)IBA 07/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2013
1	spasmolytic polypeptideIBA 10/2013
1	ImmunosorbentsIBA 07/2013
1	Fluticasone (Cutivate)FDA LinkGeneric 07/2013

Therapy/Procedure

17	Therapeutics 05/2023 - 05/2008
4	Drug Therapy (Chemotherapy) 01/2020 - 07/2016
2	Intraperitoneal Injections 01/2012 - 11/2009
1	Molecular Targeted Therapy 01/2023
1	Radioimmunotherapy 05/2022